These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6218974)

  • 1. Cefoperazone (Cefobid, Pfizer).
    Lyon JA
    Drug Intell Clin Pharm; 1983 Jan; 17(1):7-11. PubMed ID: 6218974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.
    Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
    Drugs; 1981 Dec; 22(6):423-60. PubMed ID: 6459224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone.
    Funk EA; Strausbaugh LJ
    Pharmacotherapy; 1982; 2(4):185-96. PubMed ID: 6221236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.
    Fitzpatrick BJ; Standiford HC
    Pharmacotherapy; 1982; 2(4):197-212. PubMed ID: 6221237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences among moxalactam, cefoperazone, and cefotaxime in activity against multiple-antibiotic-resistant gram-negative bacteria.
    Preston DA
    Rev Infect Dis; 1982; 4 Suppl():S516-21. PubMed ID: 6296965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide clinical experience with cefoperazone.
    Gerber AU; Craig WA
    Drugs; 1981; 22 Suppl 1():108-18. PubMed ID: 6456884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
    Neu HC
    Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials with cefoperazone in the field of internal medicine in Japan.
    Mashimo K; Kunii O
    Clin Ther; 1980; 3(Spec Issue):159-72. PubMed ID: 6446392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory evaluation of cefoperazone.
    Sarver DK; Christensen GD; Hester MG; Ling FW; Pate JW; Rosenberg EW; Anderson GD; Bisno AL
    Clin Ther; 1981; 4(3):164-74. PubMed ID: 6458360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
    Garzone P; Lyon J; Yu VL
    Drug Intell Clin Pharm; 1983 Sep; 17(9):615-22. PubMed ID: 6311502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with cefoperazone in biliary tract infections.
    Mashimo K
    Drugs; 1981; 22 Suppl 1():100-7. PubMed ID: 6456883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gram-negative bacterial toe web infection: successful treatment with a new third generation cephalosporin.
    Eaglstein NF; Marley WM; Marley NF; Rosenberg EW; Hernandez AD
    J Am Acad Dermatol; 1983 Feb; 8(2):225-8. PubMed ID: 6219139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical studies on cefoperazone (author's transl)].
    Toyonaga Y; Kurosu Y; Yoshikawa H; Kumagai K; Takahashi T; Hori M
    Jpn J Antibiot; 1980 Aug; 33(8):820-40. PubMed ID: 6451729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoperazone sodium (Cefobid).
    Med Lett Drugs Ther; 1983 Mar; 25(631):29-30. PubMed ID: 6219275
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory and clinical studies on cefoperazone in pediatrics treatment (author's transl)].
    Motohiro T; Takechi T; Soejima N; Watari H; Oohashi K; Sakata Y; Nishiyama T; Ezaki Y; Yokoyama T; Nakajima T; Komatsu Y; Ishimoto K; Tominaga K; Yamashita F; Takeya S; Yamamoto M; Ohkita R; Iriki T
    Jpn J Antibiot; 1980 Sep; 33(9):943-58. PubMed ID: 6452544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
    Daschner FD; Steffens A; Mählmann M; Metzger M
    Arzneimittelforschung; 1982; 32(5):531-3. PubMed ID: 6213241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.